Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors
- 31 December 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 73 (3) , 359-366
- https://doi.org/10.1016/j.radonc.2004.07.018
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Non-Invasive PET and Spect Imaging of Tissue Hypoxia Using Isotopically Labeled 2-NitroimidazolesPublished by Springer Nature ,2003
- Hypoxic Heterogeneity in Human TumorsAmerican Journal of Clinical Oncology, 2001
- Relationship of hypoxia to metastatic ability in rodent tumoursBritish Journal of Cancer, 2001
- Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Hypoxic stress proteins: Survival of the fittestSeminars in Radiation Oncology, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]British Journal of Cancer, 1995
- Pretreatment oxygenation profiles of human soft tissue sarcomasInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology, 1993
- Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studiesRadiotherapy and Oncology, 1991